PropForma Lens: CRE Underwriting & Excel Models

Turn LoopNet & Crexi listings into live-formula Excel underwriting models. Cap rate, DSCR, IRR and sensitivity in one click.

PropForma Lens turns a commercial real estate listing into a complete Excel underwriting model in one click. Open a property on LoopNet or Crexi. PropForma Lens reads the price, size, NOI and location from the page, shows the numbers that matter, and exports a model your team can audit, edit and send to a lender, partner or investment committee. INSTANT TRIAGE IN THE POPUP • Cap rate, DSCR (debt service coverage), year-1 cash-on-cash and 10-year levered IRR • Change leverage, interest rate, amortization, vacancy, expenses, growth and exit assumptions and every number updates • Save your own default assumptions once and every listing starts from them A REAL EXCEL MODEL, NOT A DATA DUMP • Summary with key metrics, sources and uses and a 10-year snapshot • Assumptions sheet that drives every calculation • 10-year cash flow with sale, IRR and equity multiple • Annual debt schedule (interest, principal, balance) • Sensitivity tables for interest rate, leverage and purchase price • Rent roll template with occupancy and reconciliation • Every calculated cell is a live Excel formula BUILT TO BE TRUSTED • Nothing is invented: if a listing has no price, NOI or rent roll, the workbook says so and leaves the cell for you • The Summary lists every assumption you should verify, such as an estimated NOI or a modeled expense ratio • Everything runs in your browser. Your assumptions and deals are never uploaded WHO IT IS FOR Commercial real estate brokers, acquisition analysts, investors, lenders and anyone screening deals who is tired of copying numbers into a spreadsheet. PRICING Free: 3 exports every 24 hours, full workbook, no account needed. Pro: $19 per month for unlimited exports. Cancel anytime, 14-day money-back guarantee. PropForma Lens is an independent product and is not affiliated with, endorsed by or sponsored by CoStar Group, LoopNet or Crexi. Outputs are screening estimates, not investment advice.